| Q34630040 | 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo |
| Q39622833 | A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins |
| Q34603199 | Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae |
| Q35078163 | Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotide |
| Q82705613 | Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways |
| Q33490618 | Blocking TLR2 activity attenuates pulmonary metastases of tumor |
| Q50026432 | Bryostatin-1 alleviates experimental multiple sclerosis. |
| Q38687394 | Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis. |
| Q35165584 | Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis |
| Q33638740 | Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response |
| Q61960513 | Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE |
| Q39379165 | DNA repair and systemic lupus erythematosus |
| Q55318936 | Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88. |
| Q45984203 | Different IL-17-secreting TLR(+) T cell subsets are associated with disease activity in multiple sclerosis. |
| Q35027815 | Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection |
| Q36186594 | Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients? |
| Q37778622 | Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm |
| Q37772578 | Endogenous toll-like receptor ligands and their biological significance |
| Q58546956 | Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease |
| Q52568075 | Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis. |
| Q34208023 | Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice |
| Q26745562 | Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology |
| Q30853672 | Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis |
| Q54342319 | Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis. |
| Q58855373 | Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model |
| Q93050874 | Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis |
| Q33734635 | Inhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Experimental Autoimmune Encephalomyelitis Induced in Mice |
| Q38156767 | Initial immunopathogenesis of multiple sclerosis: innate immune response. |
| Q38118170 | Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis |
| Q37586377 | Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury |
| Q38192651 | Interferons in the central nervous system: a few instruments play many tunes. |
| Q37335014 | Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis |
| Q40135764 | MicroRNA-146a Promotes Oligodendrogenesis in Stroke. |
| Q37844405 | MicroRNAs: the fine-tuners of Toll-like receptor signalling |
| Q22252213 | Microbial view of central nervous system autoimmunity |
| Q42559666 | Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells |
| Q37805517 | Modulation of toll-like receptor function has therapeutic potential in autoimmune disease |
| Q37574400 | Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration |
| Q83264891 | Neuronal modulation of the immune response |
| Q84233203 | Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis |
| Q61709508 | Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE |
| Q33890130 | Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation |
| Q27000682 | Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview |
| Q45148973 | Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis |
| Q50920042 | Reciprocal effects of Guizhi decoction to the Guizhi decoction syndrome by toll-like receptor mRNA expression and cytokines secretion. |
| Q64263117 | Regulation of Toll-Like Receptor (TLR) Signaling Pathway by Polyphenols in the Treatment of Age-Linked Neurodegenerative Diseases: Focus on TLR4 Signaling |
| Q36039356 | Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway |
| Q27027324 | Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome |
| Q33787624 | Role of the innate immune system in the pathogenesis of multiple sclerosis |
| Q37021687 | Role of toll-like receptors in multiple sclerosis |
| Q35105181 | Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs) |
| Q58454162 | Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms |
| Q91150762 | TLR signals license CD8 T cells to destroy oligodendrocytes expressing an antigen shared with a Listeria pathogen |
| Q33714200 | TLR-4-dependent and -independent mechanisms of fetal brain injury in the setting of preterm birth |
| Q37957689 | TLR-dependent T cell activation in autoimmunity. |
| Q90335945 | TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development |
| Q42271141 | TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells |
| Q37539049 | Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis. |
| Q33792227 | Th17 cytokines and vaccine-induced immunity |
| Q26747427 | The Autoimmune Ecology |
| Q52668332 | The Role of Astrocytes in Multiple Sclerosis. |
| Q41585090 | The contribution of direct TLR signaling to T cell responses. |
| Q47611584 | The hygiene hypothesis in autoimmunity: the role of pathogens and commensals |
| Q36054671 | The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis |
| Q33938242 | The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model |
| Q26770257 | Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases |
| Q36058919 | Toll-like receptor (TLR) and inflammasome actions in the central nervous system |
| Q42243487 | Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression |
| Q36167500 | Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation |
| Q34984865 | Toll-like receptor signaling in neural plasticity and disease |
| Q39546550 | Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis |
| Q37880364 | Toll-like receptors are key players in neurodegeneration |
| Q34510368 | Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential |
| Q37186287 | Toll-like receptors in neurodegeneration. |
| Q45207411 | Toll-like receptors promote inflammation in idiopathic inflammatory myopathies |
| Q28484146 | Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system |
| Q43735065 | Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5. |
| Q24624935 | Unexpected protective role for Toll-like receptor 3 in the arterial wall |